Suchergebnisse - "Cappuzzo, F"

PubPharm (134)

1

Rachel score : a nomogram model for predicting the prognosis of lung neuroendocrine tumors

enthalten in: Journal of endocrinological investigation | 2024

von La Salvia, A. | Marcozzi, B. | Manai, C. | +6

2

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib : primary results from the phase III MARIPOSA-2 study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Passaro, A. | Wang, J. | Wang, Y. | +40

3

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy : ATALANTE-1

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Besse, B. | Felip, E. | Garcia Campelo, R. | +89

4

KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Gallina, F. | Marinelli, D. | Melis, E. | +11

5

Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Scalera, S. | Ricciuti, B. | Mazzotta, M. | +29

6

Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2) : end-of-study results from a randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2022

von Del Mastro, L. | Poggio, F. | Blondeaux, E. | +116

CommentIn: Lancet Oncol. 2022 Dec;23(12):1482-1484. - PMID 36370715

7

MicroRNA-based signatures impacting clinical course and biology of ovarian cancer : a miRNOmics study

enthalten in: Biomarker research | 2021

von Krasniqi, E. | Sacconi, A. | Marinelli, D. | +21

8

MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study

enthalten in: Biomarker Research | 2021

von Krasniqi, E. | Sacconi, A. | Marinelli, D. | +21

9

Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2020

von Früh, M. | Panje, C. | Reck, M. | +13

10

Treatment of brain metastases in small cell lung cancer : Decision-making amongst a multidisciplinary panel of European experts

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2020

von Putora, P. | Fischer, G. | Früh, M. | +26

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]